John Ashkenas

2.1k total citations
37 papers, 1.7k citations indexed

About

John Ashkenas is a scholar working on Molecular Biology, Dermatology and Immunology. According to data from OpenAlex, John Ashkenas has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Dermatology and 6 papers in Immunology. Recurrent topics in John Ashkenas's work include Psoriasis: Treatment and Pathogenesis (4 papers), Dermatology and Skin Diseases (4 papers) and Nonmelanoma Skin Cancer Studies (4 papers). John Ashkenas is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (4 papers), Dermatology and Skin Diseases (4 papers) and Nonmelanoma Skin Cancer Studies (4 papers). John Ashkenas collaborates with scholars based in United States, Canada and Czechia. John Ashkenas's co-authors include Monty Krieger, Susan Acton, Mason W. Freeman, Marsha Penman, D. Resnick, Zena Werb, Stuart A. Ross, Hugh D. Tildesley, Mina J. Bissell and Adam J. Pearson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

John Ashkenas

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Ashkenas United States 17 557 525 220 198 173 37 1.7k
Mark A. Tepper United States 19 859 1.5× 942 1.8× 236 1.1× 235 1.2× 119 0.7× 36 2.1k
Hiroko Takeuchi Japan 23 405 0.7× 540 1.0× 163 0.7× 170 0.9× 137 0.8× 57 1.6k
Christopher J. Bagley Australia 24 673 1.2× 637 1.2× 119 0.5× 294 1.5× 119 0.7× 37 1.8k
Alois Palmetshofer Germany 21 793 1.4× 996 1.9× 273 1.2× 217 1.1× 121 0.7× 32 2.1k
Jayne Chin United States 20 1.1k 2.0× 845 1.6× 236 1.1× 478 2.4× 208 1.2× 22 2.1k
Hisamitsu Ide Japan 25 820 1.5× 333 0.6× 404 1.8× 443 2.2× 85 0.5× 124 2.4k
Dalila Darmoul France 24 870 1.6× 273 0.5× 248 1.1× 574 2.9× 91 0.5× 43 2.2k
Paola De Cesaris Italy 24 705 1.3× 717 1.4× 200 0.9× 232 1.2× 115 0.7× 42 1.8k
Kazuko Uno Japan 25 673 1.2× 565 1.1× 104 0.5× 348 1.8× 195 1.1× 100 2.2k
Tomohiro Fukaya Japan 30 626 1.1× 1.2k 2.2× 139 0.6× 344 1.7× 98 0.6× 64 2.3k

Countries citing papers authored by John Ashkenas

Since Specialization
Citations

This map shows the geographic impact of John Ashkenas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ashkenas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ashkenas more than expected).

Fields of papers citing papers by John Ashkenas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ashkenas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ashkenas. The network helps show where John Ashkenas may publish in the future.

Co-authorship network of co-authors of John Ashkenas

This figure shows the co-authorship network connecting the top 25 collaborators of John Ashkenas. A scholar is included among the top collaborators of John Ashkenas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ashkenas. John Ashkenas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rawlings, Andreea M., et al.. (2022). Acute infusion effects in relapsing multiple sclerosis patients receiving alemtuzumab under a modified prophylaxis regimen. Multiple Sclerosis and Related Disorders. 66. 104030–104030. 2 indexed citations
2.
Kives, Sari, et al.. (2020). Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids. Journal of Obstetrics and Gynaecology Canada. 42(12). 1475–1482.e2. 5 indexed citations
3.
Karpecki, Paul, Etty Bitton, Barbara Caffery, et al.. (2017). Dry Eye Diseases and Ocular Surgery: Practical Guidelines for Canadian Eye Care Practitioners. 79(4). 19–33.
4.
Guenther, Lyn, Kirk Barber, Gordon E. Searles, et al.. (2015). Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines. Journal of Cutaneous Medicine and Surgery. 19(3). 205–215. 7 indexed citations
5.
Brandwein, Joseph, Michelle Geddes, Jeannine Kassis, et al.. (2013). Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus.. PubMed. 3(2). 141–64. 12 indexed citations
6.
Ross, Stuart A., Hugh D. Tildesley, & John Ashkenas. (2011). Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes. Current Medical Research and Opinion. 27(sup3). 13–20. 130 indexed citations
7.
Ashkenas, John, et al.. (2005). Simple Enzymatic Means to Neutralize DNA Contamination in Nucleic Acid Amplification. BioTechniques. 39(1). 69–73. 4 indexed citations
8.
Ashkenas, John. (2002). . Journal of Clinical Investigation. 109(3). 289–289. 1 indexed citations
9.
Okabe, Masaru, Masahito Ikawa, & John Ashkenas. (1998). Male Infertility and the Genetics of Spermatogenesis. The American Journal of Human Genetics. 62(6). 1274–1281. 62 indexed citations
10.
Byers, Peter H. & John Ashkenas. (1998). Pedigrees—Publish? or Perish the Thought?. The American Journal of Human Genetics. 63(3). 678–681. 8 indexed citations
11.
Ashkenas, John. (1997). The DNA mystique: The gene as a cultural icon.. The American Journal of Human Genetics. 60(1). 248–250. 2 indexed citations
12.
Ashkenas, John & Peter H. Byers. (1997). The Final Stage of Gene Expression: Chaperones and the Regulation of Protein Fate. The American Journal of Human Genetics. 61(2). 267–272. 16 indexed citations
13.
Ashkenas, John. (1997). Crafting science: A sociohistory of the quest for the genetics of cancer. The American Journal of Human Genetics. 60(5). 1258–1260. 3 indexed citations
14.
Ashkenas, John. (1997). This Month in the Journal. The American Journal of Human Genetics. 61(5). i–ii. 2 indexed citations
15.
Ashkenas, John & Zena Werb. (1996). Proteolysis and the biochemistry of life-or-death decisions.. The Journal of Experimental Medicine. 183(5). 1947–1951. 52 indexed citations
16.
Ashkenas, John, John Muschler, & Mina J. Bissell. (1996). The Extracellular Matrix in Epithelial Biology: Shared Molecules and Common Themes in Distant Phyla. Developmental Biology. 180(2). 433–444. 97 indexed citations
17.
Werb, Zena, John Ashkenas, A MacAuley, & Jane F. Wiesen. (1996). Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis.. PubMed. 29(9). 1087–97. 55 indexed citations
18.
Podos, Steven D., et al.. (1994). LDLC encodes a brefeldin A-sensitive, peripheral Golgi protein required for normal Golgi function.. The Journal of Cell Biology. 127(3). 679–691. 54 indexed citations
19.
20.
Repp, Bruno H., Christina Milburn, & John Ashkenas. (1983). Duplex perception: Confirmation of fusion. Perception & Psychophysics. 33(4). 333–337. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Tepper Breakdown of academic impact, for papers by Hiroko Takeuchi Breakdown of academic impact, for papers by Christopher J. Bagley Breakdown of academic impact, for papers by Alois Palmetshofer Breakdown of academic impact, for papers by Jayne Chin Breakdown of academic impact, for papers by Hisamitsu Ide Breakdown of academic impact, for papers by Dalila Darmoul Breakdown of academic impact, for papers by Paola De Cesaris Breakdown of academic impact, for papers by Kazuko Uno Breakdown of academic impact, for papers by Tomohiro Fukaya
Rankless by CCL
2026